Copytele Inc Share Price OTC Bulletin Board
Equities
COPY
US2177211099
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
18/04 | Anixa Biosciences Welcomes Sanjay Juneja to Its Cancer Business Advisory Board | CI |
12/03 | Anixa Biosciences, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024 | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 98.57M 8.22B |
---|---|---|---|---|---|
Net income 2024 * | -14M -1.17B | Net income 2025 * | -15M -1.25B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-7.02
x | P/E ratio 2025 * |
-6.87
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.1% |
Latest transcript on Copytele Inc
Managers | Title | Age | Since |
---|---|---|---|
Amit Kumar
CEO | Chief Executive Officer | 59 | 01/12/01 |
Michael Catelani
DFI | Director of Finance/CFO | 57 | 01/16/01 |
Pamela Garzone
PRN | Corporate Officer/Principal | 69 | 07/21/07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lewis Titterton
BRD | Director/Board Member | 79 | 01/99/01 |
Amit Kumar
CEO | Chief Executive Officer | 59 | 01/12/01 |
Emily Gottschalk
BRD | Director/Board Member | 63 | 23/19/23 |
1st Jan change | Capi. | |
---|---|---|
+0.67% | 42.4B | |
+44.30% | 40.04B | |
-6.20% | 28.31B | |
+6.55% | 24.94B | |
-21.66% | 18.96B | |
+29.96% | 12.3B | |
-1.57% | 11.95B | |
+16.03% | 11.32B | |
-4.80% | 11.55B |
- Stock Market
- Equities
- ANIX Stock
- COPY Stock